Page last updated: 2024-12-06

metabutoxycaine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Metabutoxycaine is a local anesthetic that is structurally related to benzocaine. It is a white crystalline powder that is soluble in water and ethanol. Metabutoxycaine is used to relieve pain and itching associated with minor skin irritations, such as sunburn, insect bites, and poison ivy. It works by blocking the nerve impulses that transmit pain signals to the brain. Metabutoxycaine is available over-the-counter in various topical preparations, including creams, ointments, and sprays. Research on metabutoxycaine has focused on its potential applications in dentistry, ophthalmology, and dermatology. Studies have explored its efficacy and safety in treating pain and inflammation associated with dental procedures, eye surgery, and skin conditions. The compound is also being investigated for its potential use in pain management after surgery. Metabutoxycaine is generally well-tolerated, but some individuals may experience side effects such as skin irritation, redness, or itching. In rare cases, allergic reactions may occur. Metabutoxycaine is not recommended for use on open wounds or mucous membranes. It is important to consult with a healthcare professional before using metabutoxycaine, especially if you have any pre-existing medical conditions.'

metabutoxycaine: local anesthetic in operative dentistry [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19247
CHEMBL ID2110975
CHEBI ID135313
SCHEMBL ID25778
MeSH IDM0465670

Synonyms (20)

Synonym
metabutoxycaine
2'-diethylaminoethyl 3-amino-2-butoxybenzoate
benzoic acid, 3-amino-2-butoxy-, 2-(diethylamino)ethyl ester
2-butoxy-3-aminobenzoic acid beta-diethylaminoethyl ester
beta-diethylaminoethyl 2-butoxy-3-aminobenzoate
3-amino-2-butoxybenzoic acid 2-diethylaminoethyl ester
CHEBI:135313
3624-87-1
unii-amv9l2wt8k
amv9l2wt8k ,
metabutoxycaine [mi]
2-(diethylamino)ethyl 3-amino-2-butoxybenzoate
SCHEMBL25778
CHEMBL2110975
LJQWYEFHNLTPBZ-UHFFFAOYSA-N
DTXSID40189787
Q6822370
ethanol, 2-diethylamino-, 3-amino-2-butoxybenzoate
CS-0026326
HY-105613
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzoate esterEsters of benzoic acid or substituted benzoic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]